Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-30

Clinical Trial Update: POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing posaconazole versus fluconazole as first-line therapy for coccidioidomycosis has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)
  • POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Coccidioidomycosis | Phase 3 | Status: COMPLETED | Results posted: 2010-06-30